Clinical Trials | April 22, 2026
Moderna launches late-stage trial of mRNA bird flu vaccine
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The start of our Phase 3 trial for an H5 influenza vaccine marks a significant milestone
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The conclave brought together key stakeholders from across the assisted living ecosystem
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
Medical experts point to a growing body of research linking energy drinks to liver injury
Analysts expect modest revenue growth but pressure on profitability in the March quarter
The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols
Move to accelerate cancer care expansion across India
Subscribe To Our Newsletter & Stay Updated
